JAN (NYSE:JAN) Upgraded by Compass Point to Hold Rating

Compass Point upgraded shares of JAN (NYSE:JAN) to a hold rating in a research report released on Wednesday,Zacks reports.

JAN has been the topic of a number of other research reports. Royal Bank Of Canada increased their price objective on shares of JAN from $30.00 to $34.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. JPMorgan Chase & Co. boosted their target price on JAN from $30.00 to $34.00 and gave the company an “overweight” rating in a research report on Tuesday, August 18th. Morgan Stanley upped their price target on JAN from $28.00 to $31.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 18th. Zacks Research lowered JAN from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Weiss Ratings started coverage on JAN in a research note on Thursday, August 6th. They issued a “hold (c-)” rating for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.31.

JAN Stock Performance

JAN stock opened at $30.52 on Wednesday. JAN has a 12-month low of $22.76 and a 12-month high of $32.83. The company’s fifty day moving average is $30.48.

JAN (NYSE:JAN) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The business had revenue of $216.46 million for the quarter, compared to analyst estimates of $203.32 million. The firm’s revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities research analysts expect that JAN will post 0.97 EPS for the current fiscal year.

JAN Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Friday, December 18th will be paid a $0.0475 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Friday, December 18th.

Institutional Investors Weigh In On JAN

Hedge funds and other institutional investors have recently made changes to their positions in the business. Engineers Gate Manager LP acquired a new stake in shares of JAN in the 2nd quarter worth about $15,274,000. Wellington Management Group LLP acquired a new position in JAN during the 2nd quarter valued at about $8,739,000. WINTON GROUP Ltd acquired a new position in JAN during the 2nd quarter valued at about $2,985,000. Readystate Asset Management LP bought a new stake in JAN during the 2nd quarter worth approximately $1,724,000. Finally, Greenland Capital Management LP bought a new stake in JAN during the 2nd quarter worth approximately $575,000. 6.27% of the stock is owned by institutional investors.

More JAN News

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Jefferies’ upgrade to “strong buy” provides fresh analyst support for JAN and may attract additional buying from investors who follow rating changes. Zacks analyst upgrade report
• Positive Sentiment: Analysts have an average price target of approximately $31.71, modestly above the reference price of $30.52, suggesting some additional upside in the consensus outlook. JAN receives $31.71 average price target
• Neutral Sentiment: JAN’s latest quarter included revenue of $216.46 million, up 45.4% year over year and above estimates, but earnings per share of $0.05 missed consensus by $0.18. Management’s fiscal 2026 EPS guidance remains $0.95–$0.98, broadly consistent with analyst expectations of $0.97.
• Neutral Sentiment: The shares opened near their 50-day moving average of $30.48 and remain below the 52-week high of $32.83, leaving the upgraded rating and upcoming operating results as potential catalysts for further movement.

JAN Company Profile

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.